City
Epaper
AllNewsPhotos

Cipla

Cipla-ltd, Latest Marathi News

Read more

Cipla Limited is an Indian multinational pharmaceutical company, headquartered in Mumbai, India. Cipla primarily develops medicines to treat respiratory, cardiovascular disease, arthritis, diabetes, weight control and depression; other medical conditions.

Business : Pharmaceutical market reports 14 pc growth in June

Health : No definitive agreement on commercial supplies with Moderna: Cipla

National : Moderna's COVID-19 vaccine granted emergency use nod in India

National : Cipla seeks DCGI nod for import of Moderna's COVID-19 vaccine: Sources

National : COVID antibody cocktail now offered to patients at Indraprastha Apollo Hospitals

National : Pfizer tells Centre its vaccine suitable for 12 years and above

International : Pfizer to send 50 million COVID-19 vaccines to India with conditions

National : COVID antibody cocktail used to treat Donald Trump now launched in India

National : COVID-19: Production capacity of Remdesivir increased to nearly 119 lakh vials per month, says Govt

Business : Lilly signs pacts with Cipla, Lupin, Sun Pharma to accelerate availability of baricitinib for Covid-19 patients